News >

Awareness Increases of Unique Needs of AYA Lymphoma Patients

Gina Columbus @ginacolumbusonc
Published: Wednesday, Jun 21, 2017

Lisa G. Roth, MD

Lisa G. Roth, MD

As awareness of the unique needs of adolescents and young adults (AYA) with cancer increases, there are now clinical trials in Hodgkin lymphoma specifically focused on this patient population.

on Hematologic Malignancies.

OncLive: What did you discuss regarding AYA patients with Hodgkin lymphoma?

Roth: It is a unique age range, and an age range that is particularly relevant in Hodgkin lymphoma, where the peak age incidence is actually young adults. They have unique medical and psychosocial needs relative to younger pediatric patients, as well as the older adult oncology patients. 

What we talked about is some of the differences in treatment approaches and how, specifically, to approach patients in this unique age range where it’s kind of a unique situation where the patients in this age range might walk into a pediatric oncologist or a medical oncologist and receive vastly different treatments for the exact same diagnosis. We went through those specific issues, what considerations are relevant for this age group, and how you should approach treatment for patients in the AYA age range. 

How do you decide if an AYA patient should go to a pediatric or medical oncologist?

That is a very good question and there really is not a right answer here. What we have done at Weill Cornell Medicine is to create an AYA Lymphoma Program. It is a collaboration between the pediatric oncologists and the medical oncologists so that we can work together to decide what’s optimal for each patient. It is a unique opportunity to provide care for them that is specific to the needs of the patients in this age range.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x